Exhalation Delivery System vs Intranasal Spray for Nasal Polyp Treatment	
An exhalation delivery system appears to more effectively apply topical steroids to nasal polyps located in the ostiomeatal complex.
Crisaborole Safe, Efficacious in Atopic Dermatitis, With or Without Allergic Rhinitis	
The safety and efficacy of crisaborole ointment, 2%, was examined in pediatric patients with mild to moderate atopic dermatitis with and without comorbid allergic rhinitis.
Asthma Prevalence May Be Higher in Elderly With Behavioral Health Issues	
Because of the prevalence of behavioral health issues in elderly patients with asthma, appropriate behavioral health treatment may improve patient outcomes.
Adding Umeclidinium to ICS/LABA Improves Lung Function, Exacerbation Rate in Asthma	
Patients with asthma that is poorly controlled by ICS/LABA therapy may experience improvement in lung function with the addition of umeclidinium and/or doubling of the corticosteroid fluticasone furoate.
Adding reslizumab to mometasone furoate enhanced clinical benefits of the intranasal corticosteroid alone in patients with uncontrolled chronic rhinosinusitis with nasal polyps and peripheral eosinophilia.
Flare Size in Skin Prick Test May Predict Oral Food Challenge Outcomes	
Larger skin flare results in pediatric patients correlated to failing certain oral food challenges, but were not predictive of requiring epinephrine.
Dupilumab Demonstrates Long-Term Efficacy, Safety for Improving Asthma Control	
Treatment with monoclonal antibody and dual IL-4/IL-13 inhibitor dupilumab was well tolerated and associated with sustained improvement in asthma control for up to 96 weeks
Omalizumab Shows Continued Efficacy for Chronic Rhinosinusitis With Nasal Polyps	
Treatment with omalizumab for up to 1 year was associated with continued improvements in symptoms of chronic rhinosinusitis with nasal polyps.
Close more info about Omalizumab Shows Continued Efficacy for Chronic Rhinosinusitis With Nasal Polyps	